A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Clinical trial NCT02900664 · COMPLETED

Trial details

NCT number: NCT02900664
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma

Start date: 2016-08-23
Primary completion: 2021-03-17
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.